Skip to main content

Squarepoint Ops LLC

Position in HROW — Harrow, Inc.

CIK 1642575 NEW YORK, NY

Position in HROW

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,767,195
-$1,128,558 QoQ
Shares Held
50,119
-15.2% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in HROW Over Time

Shares Held

Position Value (USD)

Derivatives in HROW

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
0
PutValue
$240,100
PutShares
4,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Squarepoint Ops LLC holds $163,878,430 across 40 Drug Manufacturers - Specialty & Generic names. HROW ranks #14 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HROW

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,767,195 50,119
2025-12-31 $240,100 4,900
2025-12-31 $2,895,753 59,097
2025-09-30 $231,264 4,800
2025-09-30 $2,457,902 51,015
2025-06-30 $639,996 20,956
2025-03-31 $396,340 14,900
2025-03-31 $2,951,270 110,950
2025-03-31 $840,560 31,600
2024-12-31 $1,388,970 41,400
2024-12-31 $4,181,537 124,636
2024-12-31 $4,264,205 127,100
2024-09-30 $661,991 14,724
2024-09-30 $899,200 20,000
2024-06-30 $417,800 20,000
2024-03-31 $255,087 19,281
2023-12-31 $655,558 58,532
2023-09-30 $877,619 61,073
2023-03-31 $518,779 24,517
2020-12-31 $104,175 15,186
2020-03-31 $131,163 34,336